Search

everythinglearnresearchcommunity

for

Search:↓

Gender-affirming hormone treatments need better patient-focused outcome measurements and standardized data collection.

Goserelin and oestradiol treatment slightly improved hairiness but did not significantly change sebum production or hair characteristics in mildly hirsute women.

The document concludes that gender-affirming treatments are essential for transgender individuals and outlines safe hormone therapy practices.

The document concludes that low-dose oral contraceptives and hormonal therapies can manage perimenopause symptoms and reduce some health risks, but lifestyle changes and disease screening are also important.

Testosterone therapy can help improve sexual desire and function in postmenopausal women but may cause side effects and is not FDA-approved for this use.

Bicalutamide mesotherapy improved hair density in women with hair loss and was well received.

Testosterone therapy can help women with androgen deficiency by improving energy, sex drive, and bone health with few side effects.

Testosterone replacement can help women with low libido and mood, but they need to have enough estrogen first to avoid side effects.

Bicalutamide may help treat female pattern hair loss.

Combining a GnRH agonist with a low-dose oral contraceptive is more effective and safer for treating hirsutism than using either alone.

Testosterone therapy may improve mood, well-being, and sexual function in premenopausal women, but more research is needed on its long-term safety and effectiveness.

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

The document concludes that sex hormones and related compounds have various effects on health, with both potential benefits and risks.

Transgender females can reach their target estrogen levels using estradiol patches, especially if oral treatments fail or if they're at risk for blood clots. Often, the highest dose patch is needed.

Androgen replacement therapy can improve libido and mood in women with severe androgen deficiency, but more research is needed on its long-term safety.

Estrogen alone can lower testosterone in some transfeminine people.

The treatment effectively reduced hair growth and was safe for patients with PCOS, but it needs better bleeding control.

Australian doctors experienced in adult transgender healthcare mostly prescribe intramuscular testosterone and oral estradiol, recommend mental health assessments before hormone therapy, and support improved training and guidelines.

Low-dose oral contraceptives reduced hair growth and testosterone levels in women with polycystic ovary syndrome.

Bicalutamide does not significantly affect liver enzymes and is a safe anti-androgen option for transfeminine individuals.

Healthcare providers need better education and resources to give competent and sensitive care to transgender patients.

New oral testosterone formulations show potential for safer, effective hormone replacement in men with low testosterone.

Estrogen alone may effectively suppress testosterone in some transfeminine individuals.

Hormone replacement therapy can improve menopausal skin quality, but it's not recommended just for skin due to limited evidence.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

Gender-affirming hormone therapy improves mental health and gender incongruence but requires careful management of cardiovascular and cancer risks.

Injecting 2 ml of TEEV every 4 weeks is better because it has the same benefits but fewer side effects.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

GnRH-a or orchiectomy is more effective than anti-androgens for managing hormone levels in transgender women.